Related Experiment Video
Updated: Nov 25, 2025

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic
Golam Rabbani1, Sheikh Mohammad Shariful Islam2, Muhammad Aziz Rahman3,4
1Bangladesh Betar (Radio), Ministry of Information, Dhaka, Bangladesh.
Insights
Patients with chronic obstructive pulmonary disease (COPD) face over three times the risk of mortality and severe illness from COVID-19. Identifying these individuals early is crucial for timely interventions during the pandemic.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Epidemiology
Background:
- Pre-existing chronic obstructive pulmonary disease (COPD) is a significant comorbidity.
- The impact of COPD on COVID-19 outcomes requires thorough investigation.
- Understanding risk factors for severe COVID-19 is critical for public health.
Purpose of the Study:
- To systematically review and meta-analyze the association between COPD and COVID-19 mortality.
- To assess the impact of COPD on the severity of COVID-19 illness.
- To identify high-risk patient groups for targeted interventions.
Main Methods:
- Systematic literature search across major databases (Ovid Medline, Embase, PubMed, Scopus) from December 2019 to July 2020.
- Extraction of studies reporting risk estimates (Hazard Ratio, Risk Ratio) with 95% confidence intervals.
- Meta-analysis using a random-effects model to calculate pooled estimates for mortality and severity.
Main Results:
- COVID-19 patients with COPD exhibited a significantly higher risk of mortality (RR 3.18, 95% CI 2.11-4.80).
- COPD was associated with increased COVID-19 severity (RR 3.63, 95% CI 2.48-5.31).
- Male patients demonstrated a higher risk of mortality compared to females (RR 1.20, 95% CI 1.12-1.29).
Conclusions:
- Pre-existing COPD more than triples the risk of mortality and severe outcomes in COVID-19 patients.
- Early identification of COPD patients is essential for implementing timely interventions.
- This highlights the need for focused management strategies for COPD patients during pandemics.
Abstract:
Objectives: The objective of this systematic review and meta-analysis was to investigate COVID-19 mortality and severity among patients with pre-existing COPD.Methods: We performed systematic searches in Ovid Medline, Embase via Ovid, PubMed, and Scopus from 15 December 2019 to 7 July 2020. Studies which reported the association and presented data on risk estimate (Hazard Ratio [HR]) with 95% confidence intervals (95%CIs) were extracted. A random-effects model was used to obtain the pooled estimates, and a pooled Risk Ratio (RR) was calculated. Study quality was assessed using a modified version of the Newcastle-Ottawa Scale.Results: Our meta-analysis showed an increased likelihood of mortality in COVID-19 patients with pre-existing COPD (RR 3.18, 95% CI 2.11-4.80, HR 1.90, 95%CI 1.11-3.26). Furthermore, the pooled estimate for the association between pre-existing COPD and severity due to COVID-19 was also significant (RR 3.63, 95%CI 2.48-5.31). Males had an increased risk of mortality (RR 1.20, 95%CI 1.12-1.29) compared to females.Conclusion: We found that patients with pre-existing COPD had more than 3 times higher risk of mortality and severe COVID-19. There is a need to identify patients with pre-existing COPD during the pandemic so that early interventions can be aimed at this group of patients.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

